Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-051590

bluebird bio, Inc. · BLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David Davidson
Officer — Chief Medical Officer
Period of report
Sep 1, 2017
Accepted (ET)
Sep 6, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 1, 2017M12,000$5.5004A27,977D
Common StockF2Sep 1, 2017S2,300$126.162D25,677D
Common StockSep 1, 2017S700$126.60D24,977D
Common StockF3Sep 1, 2017S9,000$130.0124D15,977D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F4$5.5004Sep 1, 2017M12,000D—Jan 16, 2023Common Stock12,00091,151D

Explanation of responses